Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. · 2019
Read Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review. by Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6452778.txt.
Introduction
Mulani and co-authors review other ways to fight the ESKAPE pathogens, six hospital germs known for shrugging off many drugs. The six are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species. Strains that build enzymes able to break even last-line drugs have left doctors short of options that work.
The options surveyed include drug pairings and boosters, phages, germ-killing peptides, tiny particles, and light-based therapy. Each is weighed for how it works and its promise in living animals. Trial status and limits count too, such as harm from peptides and the cost of making them. Pairing two or more ways earns special stress, since each can cover the other's weak spots and stretch the working life of drugs already on the shelf.
Catalog record
| CREATOR | Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 113 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |